NEPHROS INC (NEPH) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$3.58

From 52W high−36.44%

Volume47239.00

Market cap$40.00M

P/E (TTM)22.9x

P/S (TTM)1.9x

Div yield—

Key dataOct 19, 2026

Open

$3.58

From 52W high

−36.44%

Volume

47239.00

Market cap

$40.00M

ValuationView details →

P/E (Fwd)

16.2x

EV/EBITDA

19.9x

P/E (TTM)

22.9x

RSI (14)

46.0

MomentumView details →

1D Return

+0.82%

YTD Return

−25.51%

SummaryUpdated Jun 1, 2026

Nephros, Inc. (NASDAQ:NEPH) is a medical device and water filtration company founded in 1997 and headquartered in South Orange, New Jersey. The company went public in 2004 and has evolved from its original focus on renal products to become a specialized provider of water safety solutions for healthcare facilities and commercial markets. After years of losses, Nephros achieved its first profitable quarter in Q3 2024, marking a significant operational milestone for the company.

Ask drillr about NEPHROS INC →

ValuationView details →

P/E (Fwd)

16.2x

P/E (TTM)

22.9x

EV/EBITDA

19.9x

EV/Sales

1.7x

P/S (TTM)

1.9x

P/B (TTM)

3.3x

ProfitabilityView details →

Gross Margin

60.31%

Net Margin

8.38%

EBITDA Margin

8.76%

ROE (TTM)

14.51%

ROA (TTM)

11.01%

Asset Turnover

1.40x

GrowthView details →

Revenue YoY

+24.20%

EPS YoY

+28.05%

FCF YoY

—

Revenue CAGR 3Y

+23.50%

EPS CAGR 3Y

+1471.43%

EBITDA YoY

+21.24%

MomentumView details →

1D Return

+0.82%

YTD Return

−25.51%

1Y Return

−30.63%

RSI (14)

46.0

vs 50D SMA

−11.14%

vs 200D SMA

−2.55%

Capital & dividendView details →

Debt/Equity

0.07x

Current Ratio

4.07x

Quick Ratio

2.71x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$0.06

EPS Surprise

1701.80%

Beats (12Q)

6/12

Next Q EPS Est

$0.02

Avg Surprise (4Q)

464.58%

Rev Surprise

19.95%

Financials snapshotView financials →

Revenue (TTM)

20.72M

Net Income (TTM)

1.74M

Op. CF (TTM)

−661000.00

Next earningsNov 5, 2026 →

Latest newsMore news →

Nephros Inc reported Q2 2026 net revenue of $6.0 million, up 36% year-over-year, with net income of $1.2 million and diluted EPS of $0.11.75d ago

Similar companies

Harvard Bioscience, Inc.HBIO MOG Holdings Limited01942.HK Precision Optics Corporation, Inc.POCI Elegance Optical International Holdings Limited00907.HK Sharps Technology, Inc.STSS Ekso Bionics Holdings, Inc.EKSO Find similar companies →

Latest newsMore news →

Nephros Inc reported Q2 2026 net revenue of $6.0 million, up 36% year-over-year, with net income of $1.2 million and diluted EPS of $0.11.75d ago